CY1107697T1 - Χρηση της θυλακιοτροπου ορμονης στην μειωση των χρωμοσωμικων ανωμαλιων των σπερματοζωαριων στα αρσενικα - Google Patents

Χρηση της θυλακιοτροπου ορμονης στην μειωση των χρωμοσωμικων ανωμαλιων των σπερματοζωαριων στα αρσενικα

Info

Publication number
CY1107697T1
CY1107697T1 CY20071100936T CY071100936T CY1107697T1 CY 1107697 T1 CY1107697 T1 CY 1107697T1 CY 20071100936 T CY20071100936 T CY 20071100936T CY 071100936 T CY071100936 T CY 071100936T CY 1107697 T1 CY1107697 T1 CY 1107697T1
Authority
CY
Cyprus
Prior art keywords
spermal
chromosomic
males
disorders
reduce
Prior art date
Application number
CY20071100936T
Other languages
English (en)
Inventor
Leo Vincenzo De
Marca Antonio La
Original Assignee
Laboratoires Serono S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Serono S.A. filed Critical Laboratoires Serono S.A.
Publication of CY1107697T1 publication Critical patent/CY1107697T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Farming Of Fish And Shellfish (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται στην χρήση μιας ουσίας που διαθέτει FSH δραστηριότητα για την μείωση των γαμετικών χρωμοσωμικών ανωμαλιών σε έναν άρρενα, πιο συγκεκριμένα σε άνδρες που πάσχουν από ανευπλοειδία των σπερματοζωαρίων.
CY20071100936T 2003-07-25 2007-07-13 Χρηση της θυλακιοτροπου ορμονης στην μειωση των χρωμοσωμικων ανωμαλιων των σπερματοζωαριων στα αρσενικα CY1107697T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03102303 2003-07-25
EP04100760 2004-02-26
EP04766306A EP1673105B1 (en) 2003-07-25 2004-07-23 Use of follicle stimulating hormone for reduction of spermatozoa chromosomal aberration in males

Publications (1)

Publication Number Publication Date
CY1107697T1 true CY1107697T1 (el) 2013-04-18

Family

ID=34117532

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100936T CY1107697T1 (el) 2003-07-25 2007-07-13 Χρηση της θυλακιοτροπου ορμονης στην μειωση των χρωμοσωμικων ανωμαλιων των σπερματοζωαριων στα αρσενικα

Country Status (13)

Country Link
US (1) US20070037742A1 (el)
EP (1) EP1673105B1 (el)
JP (1) JP4718459B2 (el)
AT (1) ATE361092T1 (el)
CY (1) CY1107697T1 (el)
DE (1) DE602004006286T2 (el)
DK (1) DK1673105T3 (el)
ES (1) ES2284052T3 (el)
HR (1) HRP20070271T3 (el)
PL (1) PL1673105T3 (el)
PT (1) PT1673105E (el)
SI (1) SI1673105T1 (el)
WO (1) WO2005011726A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1008033B (el) * 2012-03-29 2013-11-18 Βασιλειος Τσιλιβακος Μεθοδος διερευνησης της παρουσιας ενδοκυτταριων μολυσματικων παραγοντων σε κυτταρα του σπερματος
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017557A (en) * 1987-07-24 1991-05-21 Industria Farmaceutica Serono S.P.A. Treatment of infertility with somatotrophin releasing factor
CA2053864C (en) * 1989-02-21 2001-11-20 Irving Boime Modified forms of reproductive hormones
US5508261A (en) * 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US5883073A (en) * 1997-04-03 1999-03-16 Washington University Single-chain double-alpha peptide

Also Published As

Publication number Publication date
SI1673105T1 (sl) 2007-10-31
EP1673105A1 (en) 2006-06-28
DE602004006286T2 (de) 2008-01-03
ES2284052T3 (es) 2007-11-01
ATE361092T1 (de) 2007-05-15
JP4718459B2 (ja) 2011-07-06
HRP20070271T3 (en) 2007-07-31
PL1673105T3 (pl) 2007-08-31
DE602004006286D1 (de) 2007-06-14
DK1673105T3 (da) 2007-07-02
US20070037742A1 (en) 2007-02-15
JP2006528651A (ja) 2006-12-21
WO2005011726A1 (en) 2005-02-10
PT1673105E (pt) 2007-06-20
EP1673105B1 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
EP1485381B8 (en) Azolylaminoazine as inhibitors of protein kinases
MY140767A (en) Compounds, methods and compositions
ECSP066365A (es) Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
MEP6408A (xx) Gaba pojačivači u liječenju bolesti i povezanih sa smanjenjem neuresteridnom aktivnošću
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
MXPA05013733A (es) 2-aminobenzotiazoles como agonistas inversos del receptor de cb1.
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
CY1107697T1 (el) Χρηση της θυλακιοτροπου ορμονης στην μειωση των χρωμοσωμικων ανωμαλιων των σπερματοζωαριων στα αρσενικα
EP1476423A4 (en) ARYLSULFONAMIDOBENZYLVERBINDUNGEN
MXPA06009711A (es) Uso de carboxipeptidasa g para combatir la toxicidad de antifolato.
TW200505906A (en) Selective mmp-13 inhibitors
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen
MXPA05007846A (es) Derivados de diazepanes utiles como inhibidores de lfa.
MX2007004040A (es) Uso para alfa-simpatomimeticos con estructura de 2-imidazolina.
PL1732574T3 (pl) Zastosowanie o-ATP do leczenia chorób związanych z angiogenezą
UA98926C2 (ru) Ингибитор митотических кинезинов и его использование